GLP-2 analogue
Teduglutide
Answer
Teduglutide is authorised or registered in the US, the EU, the UK, Canada, Australia, Switzerland and Brazil: 7 of the 10 registers read. Highest trial phase: Phase 4 (after approval). It has 51 registered trials, 6 of them running. Brand names on the FDA label register: Gattex.
RegulatorTrial register10 regulators' registers, read 2026-09-03 to 2026-10-03 · ClinicalTrials.gov and EU CTIS, read 2026-10-03
Not medical, legal or regulatory advice.
51 trials by status
Trial registerClinicalTrials.gov and EU CTIS · read 2026-10-03 · 20 trials have posted results
Trials first submitted per year
Trial registerClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 16 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).
Status by jurisdiction
World map| Where | Status | Register | Read |
|---|---|---|---|
| United States | FDA-approved | FDA, openfda | 2026-10-03 |
| European Union | Authorised | EMA, ema | 2026-10-03 |
| United Kingdom | Authorised | MHRA, uk-mhra | 2026-10-03 |
| Canada | Authorised | Health Canada, ca-dpd | 2026-10-03 |
| Australia | Registered | TGA, au-artg | 2026-10-03 |
| Switzerland | Authorised | Swissmedic, ch-swissmedic | 2026-10-03 |
| Brazil | Registado | ANVISA, br-anvisa | 2026-10-03 |
| Serbia | Not on the register | ALIMS, rs-alims | 2026-09-03 |
| Singapore | Not on the register | HSA, sg-hsa | 2026-09-03 |
| Turkey | Not on the register | TITCK, tr-titck | 2026-09-03 |
An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.
Side effects
Trial registerCHANGE ALERTS
Get an email when this changes
One email when the status of Teduglutide changes on the register. You confirm your address first.
REGISTERED TRIALS
Newest 10 of 51 trials
| NCT06973304 | A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome running, but no longer enrolling · register updated 2026-09-08 |
|---|---|
| NCT05023382 | A Study of Teduglutide in Japanese People With Short Bowel Syndrome completed · register updated 2026-08-07 |
| NCT07537686 | Glucagon-like Peptide 2 (GLP-2) in Undernourished Women Improving From Histology-Confirmed Environmental Enteric Dysfunction (EED) not yet recruiting participants · register updated 2026-04-17 |
| NCT07319832 | A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome currently recruiting participants · register updated 2026-03-13 |
| NCT07400783 | TED_ORG: Study on Short Bowel Syndrome currently recruiting participants · register updated 2026-02-10 |
| NCT05561647 | A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey) currently recruiting participants · register updated 2026-01-26 |
| NCT01990040 | Registry for Participants With Short Bowel Syndrome running, but no longer enrolling · register updated 2025-10-10 |
| NCT03562130 | Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pedi completed · register updated 2025-09-11 |
| NCT05371028 | A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada completed · register updated 2025-04-06 |
| NCT02954458 | Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS) completed · register updated 2025-03-28 |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.